AG01E47U

34273-10-4 | saralasin

Chemical structure of saralasin, CAS 34273-10-4
AG01E47U
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 34273-10-4
Catalog Number AG01E47U(AGN-PC-0R9NH5)
Chemical Name saralasin
IUPAC Name (2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid
InChI InChI=1S/C42H65N13O10/c1-22(2)33(53-35(58)28(50-32(57)20-45-6)9-7-15-47-42(43)44)38(61)51-29(17-25-11-13-27(56)14-12-25)36(59)54-34(23(3)4)39(62)52-30(18-26-19-46-21-48-26)40(63)55-16-8-10-31(55)37(60)49-24(5)41(64)65/h11-14,19,21-24,28-31,33-34,45,56H,7-10,15-18,20H2,1-6H3,(H,46,48)(H,49,60)(H,50,57)(H,51,61)(H,52,62)(H,53,58)(H,54,59)(H,64,65)(H4,43,44,47)/t24-,28-,29-,30-,31-,33-,34-/m0/s1
InChI Key PFGWGEPQIUAZME-NXSMLHPHSA-N
MDL Number MFCD00167510
Molecular Formula C42H65N13O10
Molecular Weight 912.0466
SMILES CNCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)O
UNII H2AFV2HE66
Synonyms
(Sar(1),Ala(8))ANGII, (Sar1,Val5,Ala8)Angiotensin II, 1 Sar 8 Ala Angiotensin II, 1 Sarcosine 8 Alanine Angiotensin II, 1-Sar-8-Ala Angiotensin II, 1-Sarcosine-8-Alanine Angiotensin II, Angiotensin II, 1-Sar-8-Ala, Angiotensin II, 1-Sarcosine-8-Alanine, angiotensin II, Sar(1)-Ala(8)-, angiotensin II, sarcosyl(1)-alanine(8)-, Anhydrous Saralasin Acetate, Hydrated Saralasin Acetate, Sar-Arg-Val-Tyr-Val-His-Pro-Ala, Saralasin, Saralasin Acetate, Saralasin Acetate, Anhydrous, Saralasin Acetate, Hydrated, Saralasin, 34273-10-4, UNII-H2AFV2HE66, (Sar1,Val5,Ala8)-Angiotensin II, CHEMBL938, H2AFV2HE66, Saralasinum [INN-Latin], Saralasin [INN:BAN], Saralasine [INN-French], Saralasina [INN-Spanish], Saralasina, Saralasine, Saralasinum, (1-(N-Methylglycin) 5-L-valin, 8-L-alanin)angiotensin II, Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine-, NCGC00166135-01, N-(1-(N-(N-(N-(N-(N2-(N-methylglycly)-L-arginyl)-L-valyl)-L-tyrosyl)-L-valyl)-L-histidyl)-L-prolyl)-L-alanine, SCHEMBL23, AC1O44IX, DSSTox_CID_26549, DSSTox_RID_81710, DSSTox_GSID_46549, DTXSID2046549, CHEBI:135894, Tox21_112332, BDBM50009338, BDBM50229504, AKOS024456428, ZINC169289386, NCGC00167316-01, CAS-34273-10-4, FT-0630581, Sar-Arg-Val-Tyr-Val-His-Pro-Ala (sarlasin), [Sar1-Arg2-Val3-Tyr4-Val5-His6-Pro7-Ala8], C-23576, (2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid, (S)-2-((S)-1-((6S,9S,12S,15S,18S)-18-((1H-imidazol-4-yl)methyl)-6-(3-guanidinopropyl)-12-(4-hydroxybenzyl)-9,15-diisopropyl-4,7,10,13,16-pentaoxo-2,5,8,11,14,17-hexaazanonadecane)pyrrolidine-2-carboxamido)propanoic acid, (S)-2-((S)-1-((S)-2-((S)-2-((S)-2-((S)-2-((S)-5-(diaminomethyleneamino)-2-(2-(methylamino)acetamido)pentanamido)-3-methylbutanamido)-3-(4-hydroxyphenyl)propanamido)-3-methylbutanamido)-3-(1H-imidazol-5-yl)propanoyl)pyrrolidine-5-carboxamido)propanoic acid, aralasin, Saralasin acetate, Saralasin acetate hydrate, Sar-Arg-Val-Tyr-Val-His-Pro-Ala, C42H65N13O10, CID6324663, C42-H65-N13-O10, Angiotensin II, 1-L-sarcosine-5-L-valine-8-L-alanine-, 1-(N-Methylglycine)-5-L-valine-8-L-alanineangiotensin II,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited